- Tytuł:
- Fludarabine and cyclophosphamide in combination with alemtuzumab in patients with primary high-risk, relapsed or refractory chronic lymphocytic leukemia.
- Autorzy:
- Źródło:
- Leukemia [Leukemia] 2012 Dec; Vol. 26 (12), pp. 2549-52. Date of Electronic Publication: 2012 May 15.
- Typ publikacji:
- Clinical Trial, Phase II; Letter; Multicenter Study; Research Support, Non-U.S. Gov't
- MeSH Terms:
-
Salvage Therapy*
Antineoplastic Combined Chemotherapy Protocols /*therapeutic use
Drug Resistance, Neoplasm/*drug effects
Leukemia, Lymphocytic, Chronic, B-Cell/*drug therapy
Neoplasm Recurrence, Local/*drug therapy
Adult ; Aged ; Alemtuzumab ; Antibodies, Monoclonal, Humanized/administration & dosage ; Cyclophosphamide/administration & dosage ; Female ; Follow-Up Studies ; Humans ; Leukemia, Lymphocytic, Chronic, B-Cell/mortality ; Male ; Middle Aged ; Neoplasm Recurrence, Local/mortality ; Prognosis ; Prospective Studies ; Risk Factors ; Survival Rate ; Vidarabine/administration & dosage ; Vidarabine/analogs & derivatives
Raport